UNC Lineberger Comprehensive Cancer Center
This sponsor has funded 1 studies across 1 countries.
| EU PAS ID | Status | Title | Protocol uploaded | Results uploaded |
|---|---|---|---|---|
| 22355 | Ongoing | Assessing the generalizability of all-cause mortality from the MOSAIC trial to older adults diagnosed with stage II and III colon cancer in... | Yes | No |
PAS by Risk Management Plan (RMP) requirement
UNC Lineberger Comprehensive Cancer Center
The RMP for a medical product outlines strategies to identify, assess, and mitigate risks, including PAS for further evaluation.
Category 1 studies are imposed as condition of marketing authorisation.
Category 2 studies are imposed as specific obligation of marketing authorisation.
Category 3 studies are required under other circumstances.
PAS by study status
UNC Lineberger Comprehensive Cancer Center
The study status is defined according to the timeline dates specified.
Planned studies have not collected any data yet.
Ongoing studies collect data and should publish protocols as soon as possible.
Finalised studies should publish results in the first two weeks after finalisation.
Countries
UNC Lineberger Comprehensive Cancer Center
1 Study countries specified are the following:
- United States